DE60020269D1 - Verwendung von interleukin-6 antagonisten zur behandlung von oestrogen-abhängigen krebs - Google Patents

Verwendung von interleukin-6 antagonisten zur behandlung von oestrogen-abhängigen krebs

Info

Publication number
DE60020269D1
DE60020269D1 DE60020269T DE60020269T DE60020269D1 DE 60020269 D1 DE60020269 D1 DE 60020269D1 DE 60020269 T DE60020269 T DE 60020269T DE 60020269 T DE60020269 T DE 60020269T DE 60020269 D1 DE60020269 D1 DE 60020269D1
Authority
DE
Germany
Prior art keywords
antagonists
treatment
interleukin
oestrogen
dependent cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60020269T
Other languages
English (en)
Other versions
DE60020269T2 (de
Inventor
John Reed
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of DE60020269D1 publication Critical patent/DE60020269D1/de
Application granted granted Critical
Publication of DE60020269T2 publication Critical patent/DE60020269T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DE60020269T 2000-03-06 2000-03-06 Verwendung von interleukin-6 antagonisten zur behandlung von oestrogen-abhängigen krebs Expired - Fee Related DE60020269T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2000/000072 WO2001066131A1 (en) 2000-03-06 2000-03-06 Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase

Publications (2)

Publication Number Publication Date
DE60020269D1 true DE60020269D1 (de) 2005-06-23
DE60020269T2 DE60020269T2 (de) 2006-01-19

Family

ID=11133493

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60020269T Expired - Fee Related DE60020269T2 (de) 2000-03-06 2000-03-06 Verwendung von interleukin-6 antagonisten zur behandlung von oestrogen-abhängigen krebs

Country Status (17)

Country Link
US (1) US7160860B2 (de)
EP (1) EP1261367B1 (de)
JP (1) JP2003525906A (de)
KR (1) KR100694005B1 (de)
AT (1) ATE295735T1 (de)
AU (1) AU2000233235A1 (de)
CA (1) CA2400711A1 (de)
CZ (1) CZ20022760A3 (de)
DE (1) DE60020269T2 (de)
DK (1) DK1261367T3 (de)
ES (1) ES2241583T3 (de)
HU (1) HUP0300117A3 (de)
MX (1) MXPA02008697A (de)
PL (1) PL356846A1 (de)
PT (1) PT1261367E (de)
SK (1) SK12412002A3 (de)
WO (1) WO2001066131A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6793678B2 (en) 2002-06-27 2004-09-21 Depuy Acromed, Inc. Prosthetic intervertebral motion disc having dampening
WO2008070863A2 (en) 2006-12-07 2008-06-12 Interventional Spine, Inc. Intervertebral implant
US8900307B2 (en) 2007-06-26 2014-12-02 DePuy Synthes Products, LLC Highly lordosed fusion cage
JP5441922B2 (ja) 2008-01-17 2014-03-12 ジンテス ゲゼルシャフト ミット ベシュレンクテル ハフツング 膨張可能な椎間インプラント及び関連するその製造方法
EP2262449B1 (de) 2008-04-05 2020-03-11 Synthes GmbH Expandierbares bandscheibenimplantat
US9526620B2 (en) 2009-03-30 2016-12-27 DePuy Synthes Products, Inc. Zero profile spinal fusion cage
US9393129B2 (en) 2009-12-10 2016-07-19 DePuy Synthes Products, Inc. Bellows-like expandable interbody fusion cage
US8979860B2 (en) 2010-06-24 2015-03-17 DePuy Synthes Products. LLC Enhanced cage insertion device
US9907560B2 (en) 2010-06-24 2018-03-06 DePuy Synthes Products, Inc. Flexible vertebral body shavers
AU2011271465B2 (en) 2010-06-29 2015-03-19 Synthes Gmbh Distractible intervertebral implant
US9402732B2 (en) 2010-10-11 2016-08-02 DePuy Synthes Products, Inc. Expandable interspinous process spacer implant
US8394129B2 (en) 2011-03-10 2013-03-12 Interventional Spine, Inc. Method and apparatus for minimally invasive insertion of intervertebral implants
US8518087B2 (en) 2011-03-10 2013-08-27 Interventional Spine, Inc. Method and apparatus for minimally invasive insertion of intervertebral implants
US8940052B2 (en) 2012-07-26 2015-01-27 DePuy Synthes Products, LLC Expandable implant
US9717601B2 (en) 2013-02-28 2017-08-01 DePuy Synthes Products, Inc. Expandable intervertebral implant, system, kit and method
US9522070B2 (en) 2013-03-07 2016-12-20 Interventional Spine, Inc. Intervertebral implant
US11426290B2 (en) 2015-03-06 2022-08-30 DePuy Synthes Products, Inc. Expandable intervertebral implant, system, kit and method
US9913727B2 (en) 2015-07-02 2018-03-13 Medos International Sarl Expandable implant
EP3474782A2 (de) 2016-06-28 2019-05-01 Eit Emerging Implant Technologies GmbH Expandierbare und winkeleinstellbare gelenkige bandscheiben-cages
CN109688981A (zh) 2016-06-28 2019-04-26 Eit 新兴移植技术股份有限公司 可扩张的、角度可调整的椎间笼
US10537436B2 (en) 2016-11-01 2020-01-21 DePuy Synthes Products, Inc. Curved expandable cage
US10888433B2 (en) 2016-12-14 2021-01-12 DePuy Synthes Products, Inc. Intervertebral implant inserter and related methods
US10398563B2 (en) 2017-05-08 2019-09-03 Medos International Sarl Expandable cage
US11344424B2 (en) 2017-06-14 2022-05-31 Medos International Sarl Expandable intervertebral implant and related methods
US10940016B2 (en) 2017-07-05 2021-03-09 Medos International Sarl Expandable intervertebral fusion cage
US11446156B2 (en) 2018-10-25 2022-09-20 Medos International Sarl Expandable intervertebral implant, inserter instrument, and related methods
US11426286B2 (en) 2020-03-06 2022-08-30 Eit Emerging Implant Technologies Gmbh Expandable intervertebral implant
US11850160B2 (en) 2021-03-26 2023-12-26 Medos International Sarl Expandable lordotic intervertebral fusion cage
US11752009B2 (en) 2021-04-06 2023-09-12 Medos International Sarl Expandable intervertebral fusion cage
US12090064B2 (en) 2022-03-01 2024-09-17 Medos International Sarl Stabilization members for expandable intervertebral implants, and related systems and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276555B1 (it) * 1995-04-28 1997-11-03 Angeletti P Ist Richerche Bio Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni
IT1285790B1 (it) * 1996-09-24 1998-06-24 Angeletti P Ist Richerche Bio Adenovirus difettivi ricombinanti che codificano per mutanti di interleuchina 6 umana (hil-6) con attivita' antagonista o
GB9621095D0 (en) * 1996-10-09 1996-11-27 Imperial College Novel system
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation

Also Published As

Publication number Publication date
KR100694005B1 (ko) 2007-03-12
CA2400711A1 (en) 2001-09-13
US20050090443A1 (en) 2005-04-28
PL356846A1 (en) 2004-07-12
ES2241583T3 (es) 2005-11-01
KR20020079984A (ko) 2002-10-21
SK12412002A3 (sk) 2002-12-03
EP1261367B1 (de) 2005-05-18
WO2001066131A1 (en) 2001-09-13
CZ20022760A3 (cs) 2003-03-12
DE60020269T2 (de) 2006-01-19
AU2000233235A1 (en) 2001-09-17
US7160860B2 (en) 2007-01-09
ATE295735T1 (de) 2005-06-15
HUP0300117A3 (en) 2005-09-28
HUP0300117A2 (hu) 2003-04-28
EP1261367A1 (de) 2002-12-04
MXPA02008697A (es) 2003-04-14
JP2003525906A (ja) 2003-09-02
PT1261367E (pt) 2005-09-30
DK1261367T3 (da) 2005-09-12

Similar Documents

Publication Publication Date Title
DE60020269D1 (de) Verwendung von interleukin-6 antagonisten zur behandlung von oestrogen-abhängigen krebs
ATE453653T1 (de) Platinkomplexe zur behandlung von tumoren
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
DE60122767D1 (de) Indoly-lsulphonyl-verbindungen zur behandlung von störungen des zns
DE60118889D1 (de) Farnesyl protein transferase inhibitoren zur behandlung von brustkrebs
NO20055741D0 (no) Nye kjemiske forbindelser
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
ATE313326T1 (de) VERWENDUNG VON CABERGOLIN ZUR BEHANDLUNG VON ßRESTLESS LEGS SYNDROMß
BG66080B1 (bg) Заместени тиоацетамиди
DE60136826D1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
DE602005007220D1 (de) Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
ATE353667T1 (de) Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges
ATE346147T1 (de) Zusammensetzungen und methoden zur wundheilung
DE50310038D1 (de) Hemmstoffe der urokinase, ihre herstellung und verwendung
DK1234025T3 (da) Humane enzymer fra metalloproteasefamilien
AU2001233917A1 (en) Bcmp-7 as marker for diagnosis of breast cancer
ATE423129T1 (de) Inhibitoren von lyn-verbundener signaltransduktion (last) und deren verwendung zur behandlung von prostatakrebs
ATE339208T1 (de) Verwendung von progesteronrezeptorhemmern zur behandlung von steroid-resistentem brustkrebs
DE60213365D1 (de) Verwendung von mglur5 antagonisten zur behandlung von pruritischen zuständen
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
DE60231971D1 (de) Ndet, und seine verwendung zur behandlung von krebs
DE60209886D1 (de) Tie2 rezeptor-kinase-inhibitoren zur behandlung von angiogenen erkrankungen
ATE267194T1 (de) Medikamente geeignet zur behandlung von proliferativen erkrankungen
DE602005025459D1 (de) Ephb4-bindende antikörper zur inhibierung von angiogenese und tumorwachstum

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee